# A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy

> **NCT03608020** · PHASE1,PHASE2 · TERMINATED · sponsor: **BioMimetix JV, LLC** · enrollment: 35 (actual)

## Conditions studied

- Multiple Brain Metastases

## Interventions

- **DRUG:** BMX-001
- **RADIATION:** Whole Brain Radiation Therapy

## Key facts

- **NCT ID:** NCT03608020
- **Lead sponsor:** BioMimetix JV, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-04
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-04-15
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Cessation of grant funding
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03608020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03608020, "A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03608020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*